News
Regeneron develops, manufactures, and markets medicines for serious diseases with a primary focus on immunology, ophthalmology, oncology, and rare conditions. Its scientific model centers on a robust ...
Key Points Non-GAAP earnings per share of $1.62 in Q2 2025 beat expectations by 20%, while GAAP revenue slightly missed, declining 0.3% year over year compared to Q2 2024. Gross margin expanded by 2.3 ...
Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).
The chip designer's results and guidance were not good enough to support its highly valued stock, but its attractive business ...
Key Points - Non-GAAP earnings per share were $0.74 for the fiscal second quarter ended June 30, 2025, beating estimates by $0.03 (non-GAAP). Revenue reached $1,140.4 million for the fiscal second ...
Zacks Investment Research on MSN1d
ITT Beats Q2 Earnings Estimates, Raises 2025 EPS View
ITT Inc.’s ITT second-quarter 2025 adjusted earnings of $1.64 per share surpassed the Zacks Consensus Estimate of $1.62. The ...
How to calculate earnings per share (EPS) Let's walk through an example EPS calculation using Netflix (NFLX -0.34%). For its most recent fiscal year, the company reported a net income of ...
Apple has just reported its third-quarter results. Here are 10 key takeaways from the iPhone and Mac maker's April-June 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback